250 related articles for article (PubMed ID: 15084475)
1. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells.
Taniyama Y; Ushio-Fukai M; Hitomi H; Rocic P; Kingsley MJ; Pfahnl C; Weber DS; Alexander RW; Griendling KK
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C494-9. PubMed ID: 15084475
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells.
Ushio-Fukai M; Alexander RW; Akers M; Yin Q; Fujio Y; Walsh K; Griendling KK
J Biol Chem; 1999 Aug; 274(32):22699-704. PubMed ID: 10428852
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
6. Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.
Nazarewicz RR; Salazar G; Patrushev N; San Martin A; Hilenski L; Xiong S; Alexander RW
J Biol Chem; 2011 Jan; 286(4):2886-95. PubMed ID: 21097843
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
Li F; Malik KU
J Pharmacol Exp Ther; 2005 Mar; 312(3):1043-54. PubMed ID: 15525798
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
9. Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat.
Maizels ET; Mukherjee A; Sithanandam G; Peters CA; Cottom J; Mayo KE; Hunzicker-Dunn M
Mol Endocrinol; 2001 May; 15(5):716-33. PubMed ID: 11328854
[TBL] [Abstract][Full Text] [Related]
10. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.
Meloche S; Landry J; Huot J; Houle F; Marceau F; Giasson E
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H741-51. PubMed ID: 10924074
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells.
Haider UG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM
Mol Pharmacol; 2002 Oct; 62(4):772-7. PubMed ID: 12237323
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
14. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils.
Rane MJ; Coxon PY; Powell DW; Webster R; Klein JB; Pierce W; Ping P; McLeish KR
J Biol Chem; 2001 Feb; 276(5):3517-23. PubMed ID: 11042204
[TBL] [Abstract][Full Text] [Related]
15. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
Li XA; Bianchi C; Sellke FW
J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.
Yoshimoto T; Fukai N; Sato R; Sugiyama T; Ozawa N; Shichiri M; Hirata Y
Endocrinology; 2004 Jul; 145(7):3331-7. PubMed ID: 15070851
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2(+)-dependent phospholipase A2.
Li F; Malik KU
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2306-16. PubMed ID: 15637121
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of Ca2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells.
Blanc A; Pandey NR; Srivastava AK
Antioxid Redox Signal; 2004 Apr; 6(2):353-66. PubMed ID: 15025937
[TBL] [Abstract][Full Text] [Related]
19. OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells.
Chien MW; Chien CS; Hsiao LD; Lin CH; Yang CM
J Lipid Res; 2003 Sep; 44(9):1667-75. PubMed ID: 12810818
[TBL] [Abstract][Full Text] [Related]
20. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha.
Motley ED; Eguchi K; Gardner C; Hicks AL; Reynolds CM; Frank GD; Mifune M; Ohba M; Eguchi S
Hypertension; 2003 Mar; 41(3 Pt 2):775-80. PubMed ID: 12623995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
